The Electromagnetics and Novel Applications Lab (ENAL) of the University of Cyprus announces the implementation of a new project with the acronym “PLASMA-TReatS-TUMORS” and titled “Plasma Transport of Reactive Species on Tumors”.
The aim of the intersectoral project “PLASMA-TReatS-TUMORS” is to shine a light in key open questions of cancer medicine field benefiting significantly from knowledge transfer between expert researchers in physical, electrical and mechanical engineering, and pharmaceutical sciences.
A cutting edge numerical and experimental investigation is proposed in PLASMA-TReatS-TUMORS to combine and validate a technologically advanced multidimensional plasma fluid model combined with a novel multiscale, multiphysics, in-silico modelling framework, investigate the atmospheric pressure plasma jet (APPJ) parameter space that induces regression of tumors and apoptosis of melanoma cancer cells, and identify the role of different plasma components. The plasma model will be able to predict the suitable dosage of plasma components produced with the APPJ, which is needed for cancer elimination and which will be validated with the experiments.
The official launch date of the research project was the 1st of January 2021 and the project is scheduled to run for 24 months.
For more information, you may contact Dr. Kristaq Gazeli ([email protected]) or Professor George E. Georghiou (email: [email protected] ) or navigate to the ENAL Webpage: http://www.enal.ucy.ac.cy